Market Insights Health Pharmacies OTC Products

Digestive & Intestinal Remedies (Pharmacies) - United States

United States

Revenue in the Digestives & Intestinal Remedies market is projected to reach €0.98bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.77%, resulting in a market volume of €1.07bn by 2029.
In global comparison, most revenue will be generated in China (€3,122.00m in 2024).
In relation to total population figures, per person revenues of €2.88 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in United States is experiencing steady growth due to increasing customer preferences for natural and holistic remedies, as well as the rising incidence of digestive disorders.

Customer preferences: Customers in the United States are increasingly seeking natural and holistic remedies for digestive issues. This shift in preference is driven by a growing awareness of the potential side effects of traditional pharmaceuticals and a desire for more sustainable and environmentally friendly options. As a result, there is a rising demand for herbal and plant-based remedies, probiotics, and other natural supplements that promote digestive health.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in the United States is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help restore the natural balance of bacteria in the gut and improve digestion. With an increasing focus on gut health, probiotics have become a popular choice among consumers looking for natural solutions to digestive issues. Another trend in the market is the rise of over-the-counter (OTC) digestive remedies. OTC products, such as antacids, laxatives, and anti-diarrheals, provide quick relief for common digestive problems and are easily accessible in pharmacies and supermarkets. The convenience and affordability of OTC remedies have contributed to their growing popularity among consumers.

Local special circumstances: The United States has a large aging population, which is a significant factor driving the growth of the Digestive & Intestinal Remedies market. As people age, they are more prone to digestive disorders such as acid reflux, constipation, and irritable bowel syndrome. This demographic trend has created a strong demand for digestive remedies that can alleviate these symptoms and improve overall digestive health. Additionally, the United States has a high prevalence of unhealthy lifestyle habits, such as poor diet and sedentary behavior, which can contribute to digestive problems. As a result, there is a need for effective remedies to address these issues and promote digestive wellness.

Underlying macroeconomic factors: The growth of the Digestive & Intestinal Remedies market in the United States is also influenced by macroeconomic factors such as healthcare expenditure and insurance coverage. The rising healthcare expenditure in the country allows for increased access to healthcare services, including medications and remedies for digestive disorders. Moreover, the presence of comprehensive health insurance coverage ensures that individuals have the financial means to seek treatment and purchase necessary remedies. In conclusion, the Digestive & Intestinal Remedies market in the United States is driven by customer preferences for natural and holistic remedies, the increasing popularity of probiotics, the rise of OTC remedies, the aging population, unhealthy lifestyle habits, and macroeconomic factors such as healthcare expenditure and insurance coverage. These factors contribute to the steady growth of the market and the ongoing demand for effective digestive remedies.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.